Literature DB >> 17354656

[Arterial hypertension. Factors favoring long-term compliance with therapy].

B Waeber1, F Feihl.   

Abstract

Achieving blood pressure control in every hypertensive patients remains a difficult task despite the availability of a several types of agents lowering blood pressure by different mechanisms. The choice of initial therapy is important. Starting therapy using a blocker of the renin-angiotensin system increases the probability that the patients remain on the same drug during long-term treatment. Fixed-dose combinations, by improving blood pressure control without impairing tolerability, also facilitate persistence with therapy. Furthermore, stability of treatment has a positive impact on drug-associated costs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354656

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry.

Authors:  Roland E Schmieder; Sebastian A Potthoff; Peter Bramlage; Peter Baumgart; Felix Mahfoud; Hartmut Buhck; Taoufik Ouarrak; Martina Ehmen; Jochen Senges; Anselm K Gitt
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-24       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.